| UPSA Switzerland AG - Dafalgan 500 mg, Tabletten |
| 46206 | | 01 | | Dafalgan 500 mg | | Tabletten | | N02BE01 | | Paracetamol | | 17.05.1985 | | |
|
| Composition |
| paracetamolum 500 mg, acidum stearicum, carboxymethylamylum natricum A, talcum, povidonum K 30, maydis amylum, silica colloidalis hydrica, pro compresso corresp. natrium 1.05 mg. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Paracetamole | 500 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Stearicum | | | Carboxymethylamylum Natricum A | | | Maydis Amylum | | | Povidonum K | 30 | | Pro Compresso | | | Silica Colloidalis Hydrica | | | Talcum | |
| |
|
|
